CytoVale

Cytovale, Inc. is a medical technology company headquartered in San Francisco, California, that is revolutionizing diagnostics by leveraging cell mechanics and machine learning, initially applying these innovations to sepsis—a condition where early detection can significantly improve patient outcomes. Cytovale is committed to improving human health through groundbreaking early detection technologies supported by insights into immune activation.